NO20000934L - Adipocyttspesifikke proteinhomologer - Google Patents

Adipocyttspesifikke proteinhomologer

Info

Publication number
NO20000934L
NO20000934L NO20000934A NO20000934A NO20000934L NO 20000934 L NO20000934 L NO 20000934L NO 20000934 A NO20000934 A NO 20000934A NO 20000934 A NO20000934 A NO 20000934A NO 20000934 L NO20000934 L NO 20000934L
Authority
NO
Norway
Prior art keywords
adipocyte
specific protein
protein homologs
zsig39
polypeptides
Prior art date
Application number
NO20000934A
Other languages
English (en)
Other versions
NO20000934D0 (no
Inventor
Paul O Sheppard
Jacqueline M Humes
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO20000934D0 publication Critical patent/NO20000934D0/no
Publication of NO20000934L publication Critical patent/NO20000934L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse vedrører polynukleotid- og polypeptidmolekyler for zsig39, et nytt medlem av familien av proteiner som bærer et kollagenlign- ende domene og et kuleformet domene. Polypeptidene og polynukleotidene som koder for dem, er involvert i dimeris- ering eller oligomerisering, og kan anvendes ved undersøkelse derav. Fore- liggende oppfinnelse omfatter også antistoffer mot zsig39-polypeptidene.
NO20000934A 1997-08-26 2000-02-25 Adipocyttspesifikke proteinhomologer NO20000934L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5698397P 1997-08-26 1997-08-26
PCT/US1998/017724 WO1999010492A1 (en) 1997-08-26 1998-08-26 Adipocyte-specific protein homologs

Publications (2)

Publication Number Publication Date
NO20000934D0 NO20000934D0 (no) 2000-02-25
NO20000934L true NO20000934L (no) 2000-04-26

Family

ID=22007782

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000934A NO20000934L (no) 1997-08-26 2000-02-25 Adipocyttspesifikke proteinhomologer

Country Status (11)

Country Link
US (3) US6197930B1 (no)
EP (1) EP1009829B1 (no)
JP (1) JP3492999B2 (no)
KR (1) KR20010023325A (no)
CN (1) CN1272884A (no)
AT (1) ATE324443T1 (no)
AU (1) AU744254B2 (no)
CA (1) CA2301660A1 (no)
DE (1) DE69834334T2 (no)
NO (1) NO20000934L (no)
WO (1) WO1999010492A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469158B1 (en) * 1992-05-14 2002-10-22 Ribozyme Pharmaceuticals, Incorporated Synthesis, deprotection, analysis and purification of RNA and ribozymes
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
US20020165143A1 (en) * 1997-12-03 2002-11-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1056846A1 (en) * 1998-02-23 2000-12-06 Smithkline Beecham Plc Cerebellin-2 related polypeptides and dna coding therefor
US6406884B1 (en) * 1999-06-18 2002-06-18 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
ATE397064T1 (de) 1998-11-04 2008-06-15 Serono Genetics Inst Sa Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
DE60041912D1 (de) 1999-02-10 2009-05-14 Serono Genetics Inst Sa Polymorphe marker des lsr-gens
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
AU772103B2 (en) 1999-02-19 2004-04-08 Zymogenetics Inc. Inhibitors for use in hemostasis and immune function
US20050042719A1 (en) * 1999-05-27 2005-02-24 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp5
AU5159500A (en) * 1999-05-27 2000-12-18 Zymogenetics Inc. Adipocyte complement related protein homolog zacrp7
WO2001032868A1 (en) * 1999-11-04 2001-05-10 Genset Apm1 biallelic markers and uses thereof
US6989367B2 (en) * 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US20020058617A1 (en) * 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US6579852B2 (en) * 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6566332B2 (en) * 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
IL156864A0 (en) * 2001-01-16 2004-02-08 Genset Sa Polynucleotides and polypeptides and their use in metabolic disorders
EP1422241A1 (en) 2002-11-19 2004-05-26 Alexander Steinkasserer Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
US9102726B2 (en) * 2002-12-04 2015-08-11 Argos Therapeutics, Inc. Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
US7169898B2 (en) 2002-12-04 2007-01-30 Alexander Steinkasserer Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
WO2009142759A1 (en) * 2008-05-23 2009-11-26 Argos Therapeutics, Inc. Novel soluble cd83 polypeptides, formulations and methods of use
CN102940875B (zh) * 2012-10-31 2015-09-30 中国人民解放军军事医学科学院微生物流行病研究所 Paa蛋白及由其制备的抗体与应用
SG11201510316UA (en) 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
PL3215527T3 (pl) 2014-11-05 2025-04-28 Annexon, Inc. Humanizowane przeciwciała przeciwko czynnikowi dopełniacza C1Q i ich zastosowanie
FI3380518T3 (fi) 2015-11-24 2026-05-29 Annexon Inc Antikomplementtitekijä-C1Q:n Fab-fragmentteja ja niiden käyttöjä
CN110195070B (zh) * 2019-05-31 2022-11-04 天津大学 大肠杆菌全局调控因子的突变基因crp及应用
US12486322B2 (en) 2021-12-13 2025-12-02 Annexon, Inc. Anti-complement factor C1q antibodies with single binding arms and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037640A2 (en) 1998-12-22 2000-06-29 Genentech, Inc. Compositions and methods for the treatment of tumor
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
WO1999035170A2 (en) 1998-01-05 1999-07-15 Genentech, Inc. Compositions and methods for the treatment of tumor
NZ522634A (en) 1997-12-03 2004-02-27 Genentech Inc PRO243 encoding a polypeptide with homology to chordin and antibodies and vectors
US6406884B1 (en) 1999-06-18 2002-06-18 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
CA2348157A1 (en) 1998-12-01 2000-06-08 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
KR20010103046A (ko) 1999-03-08 2001-11-17 제넨테크, 인크. 면역 관련 질환 치료용 조성물 및 치료 방법

Also Published As

Publication number Publication date
US6197930B1 (en) 2001-03-06
WO1999010492A1 (en) 1999-03-04
US20030171547A1 (en) 2003-09-11
EP1009829A1 (en) 2000-06-21
AU9036298A (en) 1999-03-16
US6482612B1 (en) 2002-11-19
CN1272884A (zh) 2000-11-08
KR20010023325A (ko) 2001-03-26
JP2001513998A (ja) 2001-09-11
CA2301660A1 (en) 1999-03-04
JP3492999B2 (ja) 2004-02-03
DE69834334T2 (de) 2007-04-26
NO20000934D0 (no) 2000-02-25
AU744254B2 (en) 2002-02-21
EP1009829B1 (en) 2006-04-26
DE69834334D1 (de) 2006-06-01
ATE324443T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
NO20000934D0 (no) Adipocyttspesifikke proteinhomologer
DK1002075T3 (da) Adipocyt-specifikke proteinhomologer
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
NZ504114A (en) Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
ES2149149T1 (es) Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion.
ATE349700T1 (de) Übergangsmetallkomplex-haltige lumineszente proteinfarben
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
DE50012863D1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
DE59708952D1 (de) Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen
DE69636437D1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
ATE355302T1 (de) N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
DE69831084D1 (de) Beta-defensine
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
WO2002059282A3 (en) Adipocyte complement related protein zacrp13
WO2000073446A3 (en) Adipocyte complement related protein homolog zacrp6
NO20015114L (no) Adipocyttkomplementbeslektet proteinhomolog zacrp2
ATE343794T1 (de) Ph-abhängige polypeptidaggregation und verwendung davon
DE69033553D1 (de) Rekombinante herstellung von laktoperoxidase
WO2002044373A3 (en) Adipocyte complement related protein zacrp12

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application